Insider Trading & Ownership - Aldeyra Therapeutics Inc. (ALDX)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Aldeyra Therapeutics Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-11
Sale
2024-03-12
8:07 pm
Aldeyra Therapeutics Inc.ALDXGreenberg Bruce
See Remarks
13,201$3.4064$44,968372,979
(Direct)
View
2024-03-11
Sale
2024-03-12
8:04 pm
Aldeyra Therapeutics Inc.ALDXMachatha Stephen
Chief Development Officer
29,768$3.3125$98,605649,156
(Indirect
Direct)
View
2024-03-11
Sale
2024-03-12
8:01 pm
Aldeyra Therapeutics Inc.ALDXBrady Todd C
President and CEO
183,238$3.1694$580,7602,552,499
(Direct)
View
2023-10-16
Sale
2023-10-18
5:15 pm
Aldeyra Therapeutics Inc.ALDXPERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
2,756,499$1.6156$4,453,3088,593,586
(Indirect)
View
2022-08-09
Purchase
2022-08-11
4:08 pm
Aldeyra Therapeutics Inc.ALDXPERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
115,000$7.5457$867,75011,350,085
(Indirect)
View
2022-08-08
Purchase
2022-08-10
4:10 pm
Aldeyra Therapeutics Inc.ALDXPERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
97,000$7.24$702,28011,235,085
(Indirect)
View
2022-08-05
Purchase
2022-08-09
4:08 pm
Aldeyra Therapeutics Inc.ALDXPERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
141,000$6.95$979,95011,138,085
(Indirect)
View
2022-08-04
Purchase
2022-08-08
4:09 pm
Aldeyra Therapeutics Inc.ALDXPERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
95,100$6.17$586,76710,997,085
(Indirect)
View
2022-08-03
Purchase
2022-08-05
4:10 pm
Aldeyra Therapeutics Inc.ALDXPERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
100,000$5.84$584,00010,901,985
(Indirect)
View
2022-08-02
Purchase
2022-08-04
4:10 pm
Aldeyra Therapeutics Inc.ALDXPERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
412,406$5.59$2,305,35010,801,985
(Indirect)
View
2022-08-01
Purchase
2022-08-03
5:16 pm
Aldeyra Therapeutics Inc.ALDXPERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
144,185$5.05$728,13410,389,579
(Indirect)
View
2022-07-29
Purchase
2022-08-02
4:27 pm
Aldeyra Therapeutics Inc.ALDXPERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
222,123$5.03$1,117,27910,245,394
(Indirect)
View
2022-07-28
Purchase
2022-08-01
5:37 pm
Aldeyra Therapeutics Inc.ALDXPERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
119,392$5$596,96010,023,271
(Indirect)
View
2022-06-23
Purchase
2022-06-27
06:42 am
Aldeyra Therapeutics Inc.ALDXJOYCE MARTIN JOSEPH
Director
4,323$3.4755$15,02523,967
(Direct)
View
2022-06-23
Purchase
2022-06-27
06:41 am
Aldeyra Therapeutics Inc.ALDXBrady Todd C
President and CEO
17,700$3.3642$59,5461,216,535
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-09
Option Award
2024-03-12
8:07 pm
N/A
2034-03-08
Aldeyra Therapeutics Inc.ALDXGreenberg Bruce
See Remarks
252,280$0372,979
(Direct)
View
2024-03-09
Option Award
2024-03-12
8:04 pm
N/A
2034-03-08
Aldeyra Therapeutics Inc.ALDXMachatha Stephen
Chief Development Officer
405,450$0649,156
(Direct)
View
2024-03-09
Option Award
2024-03-12
8:01 pm
N/A
2034-03-08
Aldeyra Therapeutics Inc.ALDXBrady Todd C
President and CEO
1,081,201$02,552,499
(Direct)
View
2023-09-07
Exercise
2023-09-11
5:42 pm
N/A
N/A
Aldeyra Therapeutics Inc.ALDXBrady Todd C
President and CEO
273,058$0.5521,654,536
(Direct)
View
2023-09-07
Exercise
2023-09-11
5:42 pm
N/A
2023-09-07
Aldeyra Therapeutics Inc.ALDXBrady Todd C
President and CEO
273,058$01,654,536
(Direct)
View
2023-09-07
Tax Withholding
2023-09-11
5:42 pm
N/A
N/A
Aldeyra Therapeutics Inc.ALDXBrady Todd C
President and CEO
73,807$7.221,654,536
(Direct)
View
2023-09-07
Exercise
2023-09-11
4:31 pm
N/A
N/A
Aldeyra Therapeutics Inc.ALDXPhillips Gary M.
Director
5,437$0.55214,812
(Direct)
View
2023-09-07
Exercise
2023-09-11
4:31 pm
N/A
2023-09-07
Aldeyra Therapeutics Inc.ALDXPhillips Gary M.
Director
5,437$014,812
(Direct)
View
2023-08-22
Exercise
2023-08-24
4:13 pm
N/A
N/A
Aldeyra Therapeutics Inc.ALDXWalker Neal
Director
9,604$0.55215,854
(Direct)
View
2023-08-22
Exercise
2023-08-24
4:13 pm
N/A
2023-09-07
Aldeyra Therapeutics Inc.ALDXWalker Neal
Director
9,604$015,854
(Direct)
View
2023-06-30
Option Award
2023-07-05
5:46 pm
N/A
2033-06-29
Aldeyra Therapeutics Inc.ALDXJOYCE MARTIN JOSEPH
Director
24,606$024,606
(Direct)
View
2023-06-30
Option Award
2023-07-05
5:43 pm
N/A
2033-06-29
Aldeyra Therapeutics Inc.ALDXPhillips Gary M.
Director
24,423$024,423
(Direct)
View
2023-06-30
Option Award
2023-07-05
5:42 pm
N/A
2033-06-29
Aldeyra Therapeutics Inc.ALDXMiller-Rich Nancy
Director
22,137$022,137
(Direct)
View
2023-06-30
Option Award
2023-07-05
5:34 pm
N/A
2033-06-29
Aldeyra Therapeutics Inc.ALDXBronstein Ben
Director
24,058$024,058
(Direct)
View
2023-06-30
Option Award
2023-07-05
5:32 pm
N/A
2033-06-29
Aldeyra Therapeutics Inc.ALDXDOUGLAS RICHARD
Director
27,350$027,350
(Direct)
View
2023-06-30
Option Award
2023-07-05
5:30 pm
N/A
2033-06-29
Aldeyra Therapeutics Inc.ALDXWalker Neal
Director
22,137$022,137
(Direct)
View
2023-06-27
Exercise
2023-06-29
4:23 pm
N/A
N/A
Aldeyra Therapeutics Inc.ALDXBronstein Ben
Director
9,604$0.55228,248
(Direct)
View
2023-06-27
Exercise
2023-06-29
4:23 pm
N/A
2023-09-07
Aldeyra Therapeutics Inc.ALDXBronstein Ben
Director
9,604$028,248
(Direct)
View
2023-02-28
Option Award
2023-03-02
4:27 pm
N/A
2033-02-27
Aldeyra Therapeutics Inc.ALDXMachatha Stephen
Chief Development Officer
220,258$0220,258
(Direct)
View
2023-02-28
Option Award
2023-03-02
4:25 pm
N/A
2033-02-27
Aldeyra Therapeutics Inc.ALDXGreenberg Bruce
See Remarks
110,028$0110,028
(Direct)
View
2023-02-28
Option Award
2023-03-02
4:22 pm
N/A
2033-02-27
Aldeyra Therapeutics Inc.ALDXBrady Todd C
President and CEO
488,750$01,705,285
(Direct)
View
2022-07-15
Option Award
2022-07-19
4:34 pm
N/A
N/A
Aldeyra Therapeutics Inc.ALDXBrady Todd C
President and CEO
604,308$0604,308
(Direct)
View
2022-07-15
Option Award
2022-07-19
4:34 pm
N/A
N/A
Aldeyra Therapeutics Inc.ALDXGreenberg Bruce
See Remarks
126,087$0133,900
(Direct)
View
2022-07-15
Option Award
2022-07-19
4:34 pm
N/A
N/A
Aldeyra Therapeutics Inc.ALDXMachatha Stephen
Chief Development Officer
255,078$0342,947
(Direct)
View
2022-06-07
Option Award
2022-06-09
5:07 pm
N/A
2032-06-06
Aldeyra Therapeutics Inc.ALDXJOYCE MARTIN JOSEPH
Director
62,394$062,394
(Direct)
View
2022-06-07
Option Award
2022-06-09
5:07 pm
N/A
2032-06-06
Aldeyra Therapeutics Inc.ALDXMiller-Rich Nancy
Director
56,131$056,131
(Direct)
View
2022-06-07
Option Award
2022-06-09
5:06 pm
N/A
2032-06-06
Aldeyra Therapeutics Inc.ALDXPhillips Gary M.
Director
61,930$061,930
(Direct)
View
2022-06-07
Option Award
2022-06-09
5:06 pm
N/A
2032-06-06
Aldeyra Therapeutics Inc.ALDXBronstein Ben
Director
61,002$061,002
(Direct)
View
2022-06-07
Option Award
2022-06-09
5:06 pm
N/A
2032-06-06
Aldeyra Therapeutics Inc.ALDXDOUGLAS RICHARD
Director
69,353$069,353
(Direct)
View
2022-06-07
Option Award
2022-06-09
5:04 pm
N/A
2032-06-06
Aldeyra Therapeutics Inc.ALDXWalker Neal
Director
56,131$056,131
(Direct)
View

Ownership
2022-05-13
4:28 pm
N/A
N/A
Aldeyra Therapeutics Inc.ALDXGreenberg Bruce
See Remarks
0$0333,685
(Direct)
View
2022-03-30
Option Award
2022-04-01
7:44 pm
N/A
2032-03-29
Aldeyra Therapeutics Inc.ALDXBrady Todd C
President and CEO
457,758$01,656,593
(Direct)
View
2022-03-30
Option Award
2022-04-01
7:37 pm
N/A
2032-03-29
Aldeyra Therapeutics Inc.ALDXReed Joshua
Chief Financial Officer
343,322$0524,825
(Direct)
View
Goto 0, 1, 2, Next